Drugmakers unveil cancer drug data at the ASCO annual meeting, while Amazon Pharmacy announces new features for caregivers, ...

Discover the major highlights from ASCO 2025, according to researchers and drug developers who attended the convention.

Each year, the American Society of Clinical Oncology annual meeting brings together the biggest names and brightest minds in ...

Karen Eubanks Jackson has reshaped the conversation around breast cancer for Black women in America—and now, with the ASCO ...

Harbinger Health has reported clinical data at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, ...

Breast cancer study results impressed at this year’s meeting, but raised new questions. Doctors also wrestled with how best ...

The first half of this year has been riddled with market volatility and geopolitical tension. But 2025’s American Society of ...

For patients with resectable gastric or gastroesophageal junction adenocarcinoma, durvalumab plus fluorouracil, leucovorin, ...

At the 2025 ASCO (American Society of Clinical Oncology) Annual Meeting, Dr. Armenian presented findings from the session ...

Colorectal cancer offered the earliest window into the trend of increased cancer incidence among those younger than age 50.

The Trump administration's proposed funding cuts to the National Institutes of Health (NIH), including the National Cancer ...

Pharmaceutical Co. Ltd.’s LYN/BTK dual inhibitor, DZD-8586, saw tumor shrinkage in 94.1% of patients with relapsed or ...